News & Alerts for FCMGView All

March is National Colorectal Cancer Awareness Month!

That means it's a great time to encourage you and your family members to take action and screen for colorectal cancer.

To the surprise of many, colorectal cancer is the second leading cause of cancer deaths in the United States, taking the lives of about 53,000 Americans each year—more than breast cancer (43,000/year) or prostate cancer (33,000/year).1 The good news is colorectal cancer may be preventable through screening and is highly treatable whendetected in early stages.2

That’s why FCMG is committed to helping make colorectal cancer screening easy and accessible for you. A variety of colorectal cancer screening options are available, including a noninvasive option offered through FCMG, called Cologuard®. Cologuard is a noninvasive stool-based test for patients at average risk that detects blood and abnormal DNA associated with colorectal cancer and precancer. The test kit is typically shipped to your home and can be picked up via UPS, and Exact Sciences Laboratories provides results to your healthcare provider within a few weeks. You can learn more about Cologuard here.

Remember: Screening is the best way to prevent colorectal cancer. Talk to your doctor at FCMG about which screening options are right for you, including Cologuard!

Please note

Cologuard is intended to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a personal or family history of colorectal cancer. Cologuard is not a replacement for colonoscopy in high risk patients. Cologuard performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older. Cologuard performance in
repeat testing has not been evaluated. The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for diagnostic colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. False positives and false negative results can occur. In a clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative). Rx only.

References:
1. Read this document for more information.
2. Visit this site for more information